Dunhill Financial’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24 Buy
16
+15
+1,500% +$259 ﹤0.01% 1762
2026
Q2
$26 Hold
1
– – ﹤0.01% 1577
2026
Q1
$13 Hold
1
– – ﹤0.01% 1809
2025
Q4
$18 Buy
+1
New +$13 ﹤0.01% 1929

Other funds holding IART

Dunhill Financial's IART Position: Q3 2026 in Review

Dunhill Financial increased its Integra LifeSciences (IART) stake by 1,500% in Q3 2026, buying an estimated $259 and bringing the position to 16 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Dunhill Financial first reported a position in IART in Q4 2025 and has held it in 4 quarters since. The position peaked at $26 in Q2 2026. 234 funds tracked by Wall St. Rank hold IART as of Q3 2026.

  • Dunhill Financial held 16 shares of Integra LifeSciences worth $24 as of Q3 2026.
  • Dunhill Financial bought 15 Integra LifeSciences shares in Q3 2026, an estimated $259.
  • Integra LifeSciences made up ﹤0.01% of Dunhill Financial's portfolio in Q3 2026, its #1762 holding.
  • Dunhill Financial first reported a position in Integra LifeSciences in Q4 2025 and has held it in 4 quarters since.
  • Dunhill Financial's Integra LifeSciences position peaked at $26 in Q2 2026.
  • 234 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Dunhill Financial's 13F filing for Q3 2026, filed 16 Nov 2026.